Physician profile
Patrick Thomas Flanagan
NPI 1205153418
$3,708.17
in general payments reported to CMS, 2019-2025
9 companies · $875 in 2025
The $875 reported for 2025 was more than what 84% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2020: $45.86 · 2021: $217 · 2022: $143 · 2023: $146 · 2024: $980 · 2025: $875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,001.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,004.82 | 2019-2021 | |
| Terumo Medical Corporation | $851.01 | 2023-2025 | Azur Cx Detachable |
| Inari Medical, INC. | $573.23 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $300.21 | 2019-2024 | |
| Abbott Laboratories | $230.45 | 2019-2023 | Jeti |
| Histosonics, INC. | $215.26 | 2024 | |
| Trisalus Life Sciences, INC. | $211.72 | 2024-2025 | Trinav Infusion System |
| Penumbra, INC. | $165.23 | 2019-2025 | Indigo System |
| Medtronic, INC. | $156.24 | 2022-2024 | Abre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Flanagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.